Ezrin and E-cadherin expression profile in cervical cytology: a prognostic marker for tumor progression in cervical cancer

• Published in: BMC cancer 2018-03, Vol.18 (1), p.349-349, Article 349
• Main Authors: Zacapala-Gómez, Ana E, Navarro-Tito, Napoleón, Alarcón-Romero, Luz Del C, Ortuño-Pineda, Carlos, Illades-Aguiar, Berenice, Castañeda-Saucedo, Eduardo, Ortiz-Ortiz, Julio, Garibay-Cerdenares, Olga L, Jiménez-López, Marco A, Mendoza-Catalán, Miguel A
• Format: Article
• Language: English
• Subjects: Adult; Biomarkers, Tumor; Cadherins - genetics; Cadherins - metabolism; Cervical cancer; Cervical cytology; Cytoskeletal Proteins - genetics; Cytoskeletal Proteins - metabolism; Disease Progression; E-cadherin; Ezrin; Female; Gene Expression; Genotype; HPV; Humans; Immunohistochemistry; Middle Aged; Papillomaviridae - genetics; Papillomavirus Infections - complications; Papillomavirus Infections - virology; Prognosis; Protein Transport; Risk Factors; SIL; Uterine Cervical Neoplasms - etiology; Uterine Cervical Neoplasms - metabolism; Uterine Cervical Neoplasms - mortality; Uterine Cervical Neoplasms - pathology; Young Adult
• ISSN: 1471-2407; 1471-2407
• DOI: 10.1186/s12885-018-4243-7

Cervical cancer (CC) is the fourth cause of mortality by neoplasia in women worldwide. The use of immunomarkers is an alternative tool to complement currently used algorithms for detection of cancer, and to improve selection of therapeutic schemes. Aberrant expression of Ezrin and E-cadherin play an important role in tumor invasion. In this study we analyzed Ezrin and E-cadherin expression in liquid-based cervical cytology samples, and evaluated their potential use as prognostic immunomarkers. Immunocytochemical staining of Ezrin and E-cadherin was performed in cervical samples of 125 patients. The cytological or histological diagnostic was performed by Papanicolaou staining or H&E staining, respectively. HPV genotyping was determined using INNO-LIPA Genotyping Extra kit and the HPV physical status by in situ hybridization. Ezrin expression in HaCaT, HeLa and SiHa cell lines was determined by immunocytochemistry, immunofluorescence and Western blot. High Ezrin expression was observed in cervical cancer samples (70%), samples with multiple infection by HR-HPV (43%), and samples with integrated viral genome (47%). High Ezrin expression was associated with degree of SIL, viral genotype and physical status. In contrast, low E-cadherin expression was found in cervical cancer samples (95%), samples with multiple infection by HR-HPV/LR-HPV (87%) and integrated viral genome (72%). Low E-cadherin expression was associated with degree of SIL and viral genotype. Interestingly, Ezrin nuclear staining was associated with degree of SIL and viral genotype. High Ezrin expression, high percent of nuclear Ezrin and low E-cadherin expression behaved as risk factors for progression to HSIL and cervical cancer. Ezrin and E-cadherin expression profile in cervical cytology samples could be a potential prognostic marker, useful for identifying cervical lesions with a high-risk of progression to cervical cancer.